tm logo
SU2C CONVERGENCE
Live/Pending
NOTICE OF ALLOWANCE - ISSUED

issued

on 30 Jan 2024

Last Applicant/ Owned by

10880 Wilshire Boulevard, Suite 1400

Los Angeles

CA

90024

Serial Number

97393935 filed on 03rd May 2022

Registration Number

N/A

Correspondent Address

Andrew D. Price

VENABLE LLP

P.O. BOX 34385

WASHINGTON,DC 20043-9998

Filing Basis

1. intent to use current

Disclaimer

NO DATA

SU2C CONVERGENCE

Promoting public awareness in the field of cancer, cancer research, and cancer prevention and treatment; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of cancer, cancer research, and cancer prevention and treatment Providing grants for research in the field of cancer; charitable fundraising SU TWO C CONVENGENCE

Classification Information


Class [036]
Insurance & Financial Services


Providing grants for research in the field of cancer; charitable fundraising

Class [035]
Advertising, Business & Retail Services


Promoting public awareness in the field of cancer, cancer research, and cancer prevention and treatment; promoting collaboration within the scientific, research and medical communities to achieve advances in the field of cancer, cancer research, and cancer prevention and treatment

Mark Details


Serial Number

No 97393935

Mark Type

No Service Mark

Attorney Docket Number

No 134235562782

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

Yes

No Basis

No

Legal History


Show more

Status DateAction Taken
30th Jan 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05th Dec 2023PUBLISHED FOR OPPOSITION
05th Dec 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
15th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
31st Oct 2023APPROVED FOR PUB - PRINCIPAL REGISTER
30th Oct 2023ASSIGNED TO LIE
30th Oct 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
30th Oct 2023TEAS/EMAIL CORRESPONDENCE ENTERED
30th May 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
29th Nov 2022NON-FINAL ACTION WRITTEN